Ludwig Enterprises

LUDG · OTC

$0.0035−$0.0035 (−50.00%)TodayMarket closed · Oct 16, 2:34 PM ET

Prev close $0.007

About LUDG

Ludwig Enterprises Inc, operates as a biotech and healthcare holding company. The company is headquartered in Pompano Beach, Florida and currently employs 5 full-time employees. The company went IPO on 2007-12-11. Its proprietary mRNA genomic technology has the potential of screening for genetic biomarkers for inflammatory-driven diseases, including, but not limited to, heart disease, diabetes, preeclampsia, cancer and long COVID. The firm employs a non-invasive cheek swab test to collect mRNA samples. Its initial product candidate is the Revealia Breast test, a non-invasive cheek swab assay designed to detect molecular signatures in mRNA expression associated with the presence of breast cancer. Its technology platform integrates three key components: non-invasive sample collection, genomic analysis, and machine learning-based interpretation.

Employees: 5
Headquarters: Pompano Beach, Florida
Listed: Dec 11, 2007
Sector: Health Care
Industry: Biotechnology
Website: ludwigent.com

Similar companies

Companies in the same industry as Ludwig Enterprises

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.